AI-Engineered Enzymes for High-Sensitivity Detection Platforms

AI-Engineered Enzymes for Diagnostic Biosensor Platforms

Clinical and point-of-care (POC) diagnostics demand:

  • High analytical sensitivity
  • Target specificity
  • Signal stability
  • Rapid response time
  • Robust manufacturing scalability

Enzyme performance is often the limiting factor in assay sensitivity and reliability.

Neoncorte Bio develops AI-optimized enzymes tailored for next-generation biosensor platforms in clinical and decentralized diagnostic settings.

enzyme based biosensors neoncorte bio

Application Areas in Diagnostic Systems

Why AI-Driven Enzyme Engineering

AI-driven modeling accelerates development cycles and improves analytical performance.
  • Diagnostic enzymes must perform under:
    • Variable storage conditions
    • Miniaturized device formats
    • Complex biological matrices
    • Strict regulatory requirements
  • Neoncorte Bio applies AI-guided protein engineering to:
    • Enhance catalytic efficiency
    • Improve thermal and shelf stability
    • Reduce background activity
    • Optimize signal kinetics
    • Adapt enzymes to specific assay chemistries
 Neoncorte Bio AI-Engineered Enzymes biosensors

What Neoncorte Bio Delivers

  • Custom enzyme engineering for diagnostic applications
  • AI-guided optimization for sensitivity and stability
  • Enzyme variants compatible with device integration
  • Scalable, fermentation-ready production candidates
  • Confidential B2B co-development programs
  • Who We Work With?
    • Diagnostic device manufacturers
    • Point-of-care technology companies
    • Clinical assay developers
    • Digital health platform providers
    • Life science tool companies

Frequently Asked Questions (FAQs)

Neoncorte Bio

Where AI Meets Biotechnology
Neoncorte Bio is at the forefront of the convergence between artificial intelligence and enzyme engineering. Our team comprises experts in computational biology, bioinformatics, and machine learning, all driven by a mission to accelerate innovation in enzyme design. By leveraging our advanced AI models, we provide unparalleled solutions that enhance efficiency, reduce costs, and push the boundaries of what's possible in enzyme engineering

Proud Member of Leading Global AI Programs

Neoncorte Bio is part of the NVIDIA Inception and Nebius for Startups programs — two of the world’s leading ecosystems for high-performance AI innovation. These partnerships strengthen our ability to deliver next-generation AI-driven protein, enzyme, and aptamer engineering.
  • NVIDIA Inception Neoncorte Bio AI life sciences company
    As a member of NVIDIA Inception, Neoncorte Bio gains access to cutting-edge GPU technologies, expert guidance, and a global AI ecosystem that supports companies from prototype to production. The program empowers us to explore new AI opportunities and build high-performance biological design pipelines powered by NVIDIA’s world-class platform.
  • Nebius AI life sciences Neoncorte Bio
    Through Nebius for Startups, we gain access to high-performance compute infrastructure optimized for large-scale AI workloads, along with hands-on technical guidance and a strong community of innovative AI companies. Nebius enables us to train and deploy complex biological models more efficiently — accelerating enzyme, protein, and aptamer design while supporting rapid scaling of our R&D pipelines.

Publications

Scientific Publication of Neoncorte Bio Team
  • Modification of natural enzymes to introduce new properties and enhance existing ones is a central challenge in bioengineering. This study is focused on the development of Taq polymerase mutants that show enhanced reverse transcriptase (RTase) activity while retaining other desirable properties such as fidelity, 5′-3′ exonuclease activity, effective deoxyuracil incorporation, and tolerance to locked nucleic acid (LNA)-containing substrates.
  • The transcriptomic data are being frequently used in the research of biomarker genes of different diseases and biological states. The most common tasks there are the data harmonization and treatment outcome prediction. Both of them can be addressed via the style transfer approach. Either technical factors or any biological details about the samples which we would like to control (gender, biological state, treatment, etc.) can be used as style components.
  • List of all Neoncorte Bio publications dedicated to Molecular Biology, Biotechnology, Artificial Intelligence and Artificial Neural Networks, published mostly by Nikolay Russkikh, CEO of Neoncorte Bio

Our Expertise in Action

With extensive experience in AI applications and software engineering tailored to the life sciences, we specialize in solving complex challenges and delivering innovative solutions for our customers. Our work demonstrates a deep understanding of cutting-edge technologies and their application in the real world.
Here are examples of the types of projects we have successfully delivered:
  • Automated NGS Data Analysis:

    Designed a production-grade solution for the automated processing, annotation, and analysis of Next-Generation Sequencing (NGS) data.
  • Single-Cell Data Integration:

    Built state-of-the-art tools for integrating multimodal single-cell data, achieving recognition for technical excellence.
  • Metagenomic Classification Algorithms:

    Developed advanced methods for classifying sequencing reads in metagenomics research.
  • High-Throughput Image Processing Pipelines:

    Engineered an efficient pipeline to process millions of sequencing images with exceptional accuracy.
  • Cell Counting via AI:

    Created a computer vision solution for precise cell counting in microphotography images, streamlining data analysis.
Get in touch with our team
Phone: +1-503-754-3958
Email: contact@neoncorte.com